HomeCompareLGHLW vs JNJ

LGHLW vs JNJ: Dividend Comparison 2026

LGHLW yields 66666.67% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LGHLW wins by $8.441837856534449e+24M in total portfolio value
10 years
LGHLW
LGHLW
● Live price
66666.67%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.441837856534449e+24M
Annual income
$8,417,001,582,403,749,000,000,000,000,000.00
Full LGHLW calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — LGHLW vs JNJ

📍 LGHLW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLGHLWJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LGHLW + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LGHLW pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LGHLW
Annual income on $10K today (after 15% tax)
$5,666,666.67/yr
After 10yr DRIP, annual income (after tax)
$7,154,451,345,043,187,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, LGHLW beats the other by $7,154,451,345,043,187,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LGHLW + JNJ for your $10,000?

LGHLW: 50%JNJ: 50%
100% JNJ50/50100% LGHLW
Portfolio after 10yr
$4.2209189282672247e+24M
Annual income
$4,208,500,791,201,874,400,000,000,000,000.00/yr
Blended yield
99.71%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

LGHLW
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LGHLW buys
0
JNJ buys
0
No recent congressional trades found for LGHLW or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLGHLWJNJ
Forward yield66666.67%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$8.441837856534449e+24M$30.3K
Annual income after 10y$8,417,001,582,403,749,000,000,000,000,000.00$4,689.40
Total dividends collected$8.44020886744369e+24M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: LGHLW vs JNJ ($10,000, DRIP)

YearLGHLW PortfolioLGHLW Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$6,677,367$6,666,666.67$10,592$272.30+$6.67MLGHLW
2$4,167,497,846$4,160,353,063.34$11,289$357.73+$4167.49MLGHLW
3$2,431,161,901,635$2,426,702,678,939.67$12,123$472.89+$2431161.89MLGHLW
4$1,325,636,209,022,888$1,323,034,865,788,139.00$13,141$629.86+$1325636209.01MLGHLW
5$675,632,775,263,916,700$674,214,344,520,262,300.00$14,408$846.81+$675632775263.90MLGHLW
6$321,867,481,182,444,260,000$321,144,554,112,911,900,000.00$16,021$1,151.60+$321867481182444.25MLGHLW
7$143,326,993,661,751,470,000,000$142,982,595,456,886,240,000,000.00$18,122$1,588.22+$143326993661751472.00MLGHLW
8$59,657,925,421,851,500,000,000,000$59,504,565,538,633,426,000,000,000.00$20,930$2,228.20+$59657925421851500544.00MLGHLW
9$23,211,471,150,187,795,000,000,000,000$23,147,637,169,986,416,000,000,000,000.00$24,792$3,191.91+$2.3211471150187796e+22MLGHLW
10$8,441,837,856,534,450,000,000,000,000,000$8,417,001,582,403,749,000,000,000,000,000.00$30,274$4,689.40+$8.441837856534449e+24MLGHLW

LGHLW vs JNJ: Complete Analysis 2026

LGHLWStock

Lion Group Holding Ltd., together with its subsidiaries, operates a trading platform for corporate clients, individual traders, and retail investors. Its trading platform offers a range of products and services comprising contracts for difference trading, insurance brokerage, futures and securities brokerage, total return swap trading, and asset management services. The company's trading platform allows users to trade various futures products on futures exchanges worldwide, including the Chicago Mercantile Exchange, Singapore Exchange, the Hong Kong Futures Exchange, and Eurex Exchange; stocks listed on the New York Stock Exchange, Nasdaq and Hong Kong Stock Exchange; and the People's Republic of China stocks listed on the Shanghai Stock Exchange and Shenzhen Stock Exchange that are eligible for the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect programs. It also creates, mints, and sells the MetaWords NFTs; and operates Lion NFT platform for buying and selling the MetaWords NFTs. The company has a strategic partnership with Dawa Future Graphic Technology Co., Ltd. to develop its Lion World Metaverse project. Lion Group Holding Ltd. was founded in 2015 and is headquartered in Singapore.

Full LGHLW Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this LGHLW vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LGHLW vs SCHDLGHLW vs JEPILGHLW vs OLGHLW vs KOLGHLW vs MAINLGHLW vs ABBVLGHLW vs MRKLGHLW vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.